Heparin is monitored by measuring the APTT.
For established thromboembolism, the APTT should be prolonged 1.5 - 2.0 times normal. The therapeutic response lessens if the APTT is less than 1.5 times normal.
Bleeding risk at this level is low unless there are predisposing risk factors. High risk patients should be treated at the lower end of the range.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page